Global Phenylketonuria Market, By Types (Classic PKU, Mild PKU, Benign PKU), Test (Diagnostic Test, Screening Test), Treatment (Drug Therapy, Dietary Therapy, Gene Therapy), Application (Household, Hospitals, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The phenylketonuria market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 8.98% in the forecast period of 2021 to 2028 and is estimated to reach 1041.01 USD million by 2028. The growing prevalence of phenylketonuria will help in escalating the growth of the healthcare analytical testing services market.
Phenylketonuria (PKU) is utilized for patients suffering from a specific illness. It is a genetic illness that people suffer from very rarely. The amplified production of phenylalanine is the symptom of this disease and leads to a diminished metabolism. This ailment mostly happens because of a defect in the genes of the person.
Major factors that are expected to boost the growth of the phenylketonuria market in the forecast period are the growing incidences of phenylketonuria, the occurrence of the pipeline drugs and the growing alertness amongst the population about the phenylketonuria. Furthermore, the increasing collaborations amongst the key market players, the development and expansion in the healthcare industry are few of the factors anticipated to further propel the growth of the phenylketonuria market. The increasing research in the field of genomics and bioinformatics and the growing research and development regarding the phenylketonuria are some of the other factors estimated to cushion the growth of the phenylketonuria market.
On the other hand, the increase in the cost of the treatment and the strict government guidelines are some of the other factors responsible for impeding the growth of the phenylketonuria market in the timeline period. In addition, the growing development and commercialization of new drugs and the developments in the health care industry will further offer advantageous opportunities for the growth of the phenylketonuria market in the coming years. However, the absence of alertness amongst the patients and physicians might further challenge the growth of the phenylketonuria market in the near future.
This phenylketonuria market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on phenylketonuria market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Phenylketonuria Market Scope and Market Size
The phenylketonuria market is segmented on the basis of type, test, therapy type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the type, the phenylketonuria market is segmented into classic phenylketonuria, mild phenylketonuria, and benign phenylketonuria.
- Based on the test, the phenylketonuria market is segmented into diagnostic test and screening test.
- Based on the therapy type, the phenylketonuria market is segmented into gene therapy, dietary therapy.
- Based on the end user, the phenylketonuria market is segmented into hospital homecare, specialty clinics, others.
Phenylketonuria Market Country Level Analysis
The phenylketonuria market is analysed and market size insights and trends are provided by country, type, test, therapy type and end user as referenced above.
The countries covered in the phenylketonuria market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the phenylketonuria market because of the suitable guidelines and the increasing government initiatives for the treatment of phenylketonuria. Furthermore, the growing consciousness, increase in the population, and the demand for the product will further boost the growth of the phenylketonuria market in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the phenylketonuria market because of the expansion of the countries it establishes. Moreover, the growing alertness about healthy living is further anticipated to propel the growth of the phenylketonuria market in the region in the coming years.
The country section of the phenylketonuria market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data
Healthcare Infrastructure growth Installed base and New Technology Penetration
The phenylketonuria market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for phenylketonuria market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the phenylketonuria market. The data is available for historic period 2010-2019.
Competitive Landscape and Phenylketonuria Market Share Analysis
The phenylketonuria market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to phenylketonuria market.
The major players covered in the phenylketonuria market report are DAIICHI SANKYO COMPANY, LIMITED, Ajinomoto Cambrooke, Inc., American Gene Technologies, Ultragenyx Pharmaceutical, Nutricia, Homology Medicines, Inc., Reckitt Benckiser Group plc, Abbott, Travere Therapeutics, Inc., Synlogic, Promin., SOM BIOTECH, S.L. Healthcare, Synthetic Biologics, Inc., Nestlé, Codexis, BioMarin, Erytech Pharma., Censa Pharmaceutical Inc., Rubius Therapeutics, Inc., among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.